Related Experiment Video
Updated: Dec 23, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?
Anne Langsted1,2,3, Børge G Nordestgaard1,2,3
1Department of Clinical Biochemistry.
Insights
Low-density lipoprotein (LDL) and lipoprotein(a) show similar causal risks for heart attack. However, lipoprotein(a) is a more significant factor for cardiovascular and all-cause mortality, potentially due to its structure.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- Lipid profiles, including low-density lipoprotein (LDL) cholesterol and lipoprotein(a) [Lp(a)], are critical in assessing CVD risk.
- Understanding the distinct causal roles of LDL and Lp(a) is essential for targeted prevention strategies.
Purpose of the Study:
- To directly compare the causal roles of LDL cholesterol and Lp(a) in cardiovascular disease and mortality.
- To review recent scientific literature on the comparative impact of LDL and Lp(a) on health outcomes.
Main Methods:
- Observational analyses of approximately 100,000 individuals from the Copenhagen General Population Study.
- Genetic analyses to determine causal risk ratios for myocardial infarction and mortality.
- Assessment of hazard ratios for myocardial infarction, cardiovascular mortality, and all-cause mortality per unit increase in LDL and Lp(a) cholesterol.
Main Results:
- On a cholesterol basis, LDL and Lp(a) demonstrated similar causal risk for myocardial infarction (HR 1.3 for LDL, 1.6 for Lp(a)).
- Genetic analyses indicated comparable causal risk ratios for myocardial infarction (2.1 for LDL, 2.0 for Lp(a)).
- Lp(a) showed a greater association with mortality risk compared to LDL (HR 1.18 vs. 1.05 for cardiovascular mortality, 1.07 vs. 1.01 for all-cause mortality per 15 mg/dl increase).
Conclusions:
- Lipoprotein(a) is a significant causal factor for cardiovascular mortality, potentially exceeding the impact of LDL cholesterol.
- The structural characteristics of Lp(a), particularly its resemblance to plasminogen via apolipoprotein(a) kringle IV-2, may contribute to its pathogenicity beyond its cholesterol content.
- Further research into Lp(a) structure and function is warranted for novel therapeutic targets.
Purpose Of Review:
To summarize the recent studies directly comparing LDL and lipoprotein(a) as causal factors for cardiovascular disease and mortality.
Recent Findings:
In approximately 100,000 individuals from the Copenhagen General Population Study for risk of myocardial infarction, in observational analyses per 39 mg/dl (1 mmol/l) cholesterol increase, the hazard ratio was 1.3 (95% confidence interval: 1.2-1.3) for LDL cholesterol and 1.6 (1.4-1.9) for lipoprotein(a) cholesterol. In corresponding genetic analyses, the causal risk ratio was 2.1 (1.3-3.4) for LDL and 2.0 (1.6-2.6) for lipoprotein(a). Also, a 15 mg/dl (0.39 mmol/l) cholesterol increase was associated with a hazard ratio for cardiovascular mortality of 1.05 (1.04-1.07) for LDL cholesterol and 1.18 (1.12-1.25) for lipoprotein(a) cholesterol. Corresponding values for all-cause mortality were 1.01 (1.00-1.01) for LDL cholesterol and 1.07 (1.04-1.10) for lipoprotein(a) cholesterol. In genetic, causal analyses, the mortality increases for elevated lipoprotein(a) appeared to be through apolipoprotein(a) kringle IV-2 rather than through lipoprotein(a) levels per se.
Summary:
On cholesterol scales, lipoprotein(a) and LDL appeared equal as causal factors for myocardial infarction; however, lipoprotein(a) was most important for mortality. Lipoprotein(a) effects may not only be due to cholesterol content but could also be due to the structure of lipoprotein(a) resembling plasminogen.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

